BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12742334)

  • 1. Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland.
    Davoren A; McParland P; Crowley J; Barnes A; Kelly G; Murphy WG
    BJOG; 2003 May; 110(5):492-6. PubMed ID: 12742334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetomaternal alloimmune thrombocytopenia.
    Ahya R; Turner ML; Urbaniak SJ;
    Transfus Apher Sci; 2001 Oct; 25(2):139-45. PubMed ID: 11761276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study.
    Doughty HA; Murphy MF; Metcalfe P; Waters AH
    Br J Haematol; 1995 Jun; 90(2):321-5. PubMed ID: 7794750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast and low-cost direct ELISA for high-throughput serological HPA-1a typing.
    Winkelhorst D; Porcelijn L; Muizelaar E; Oldert G; Huiskes E; van der Schoot CE
    Transfusion; 2019 Sep; 59(9):2989-2996. PubMed ID: 31329320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.
    Williamson LM; Hackett G; Rennie J; Palmer CR; Maciver C; Hadfield R; Hughes D; Jobson S; Ouwehand WH
    Blood; 1998 Oct; 92(7):2280-7. PubMed ID: 9746765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases.
    Davoren A; McParland P; Barnes CA; Murphy WG
    J Clin Pathol; 2002 Apr; 55(4):289-92. PubMed ID: 11919215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantibodies to human platelet glycoprotein antigens (HPA) and HLA class 1 in a cross section of Nigerian antenatal women.
    Jeremiah ZA; Atiegoba AI; Mgbere O
    Hum Antibodies; 2011; 20(3-4):71-5. PubMed ID: 22129676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review.
    Kamphuis MM; Paridaans N; Porcelijn L; De Haas M; Van Der Schoot CE; Brand A; Bonsel GJ; Oepkes D
    BJOG; 2010 Oct; 117(11):1335-43. PubMed ID: 20618318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk.
    Winkelhorst D; de Vos TW; Kamphuis MM; Porcelijn L; Lopriore E; Oepkes D; van der Schoot CE; de Haas M
    BMJ Open; 2020 Jul; 10(7):e034071. PubMed ID: 32690731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a.
    Turner ML; Bessos H; Fagge T; Harkness M; Rentoul F; Seymour J; Wilson D; Gray I; Ahya R; Cairns J; Urbaniak S
    Transfusion; 2005 Dec; 45(12):1945-56. PubMed ID: 16371049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study.
    Tiller H; Husebekk A; Skogen B; Kjeldsen-Kragh J; Kjaer M
    BJOG; 2016 Apr; 123(5):738-44. PubMed ID: 25752647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an enzyme-linked immunosorbent assay kit (GTI PakPlus) for the detection of antibodies against human platelet antigens.
    Lucas GF; Rogers SE
    Transfus Med; 1999 Mar; 9(1):63-7. PubMed ID: 10216906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive Prenatal Diagnosis of Feto-Maternal Platelet Incompatibility by Cold High Resolution Melting Analysis.
    Ferro M; Macher HC; Noguerol P; Jimenez-Arriscado P; Molinero P; Guerrero JM; Rubio A
    Adv Exp Med Biol; 2016; 924():67-70. PubMed ID: 27753021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive prenatal diagnosis by cell-free DNA screening for fetomaternal HPA-1a platelet incompatibility.
    Ferro M; Macher HC; Fornés G; Martín-Sánchez J; Jimenez-Arriscado P; Molinero P; Pérez-Simón JA; Guerrero JM; Rubio A
    Transfusion; 2018 Oct; 58(10):2272-2279. PubMed ID: 30222855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study.
    de Vos TW; Winkelhorst D; Porcelijn L; Beaufort M; Oldert G; van der Bom JG; Lopriore E; Oepkes D; de Haas M; van der Schoot E
    Lancet Haematol; 2023 Dec; 10(12):e985-e993. PubMed ID: 38407610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prenatal identification of fetal compatibility in neonatal alloimmune thrombocytopenia using amniotic fluid and variable number of tandem repeat (VNTR) analysis.
    Denomme GA; Waye JS; Burrows RF; Hayward CP; Warkentin TE; Horsewood P; Smith JW; Jelsema RD; Zuidema LJ; Kelton JG
    Br J Haematol; 1995 Nov; 91(3):742-6. PubMed ID: 8555086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C; Campbell K; Stafford P; Metcalfe P; Casbard A; Smith GA; Allen D; Ranasinghe E; Williamson LM; Ouwehand WH
    Transfusion; 2007 Jul; 47(7):1296-305. PubMed ID: 17581167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn.
    Jaegtvik S; Husebekk A; Aune B; Oian P; Dahl LB; Skogen B
    BJOG; 2000 May; 107(5):691-4. PubMed ID: 10826588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.